vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $22.2M, roughly 1.3× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -147.1%, a 193.5% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -67.6%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
GCBC vs SPRY — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $28.1M |
| Net Profit | $10.3M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | 52.0% | -147.6% |
| Net Margin | 46.3% | -147.1% |
| Revenue YoY | 23.8% | -67.6% |
| Net Profit YoY | 37.4% | -182.8% |
| EPS (diluted) | $0.60 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $28.1M | ||
| Q3 25 | $21.5M | $32.5M | ||
| Q2 25 | $20.5M | $15.7M | ||
| Q1 25 | $20.1M | $8.0M | ||
| Q4 24 | $17.9M | $86.6M | ||
| Q3 24 | $16.9M | $2.1M | ||
| Q2 24 | $16.6M | $500.0K | ||
| Q1 24 | $15.7M | $0 |
| Q4 25 | $10.3M | $-41.3M | ||
| Q3 25 | $8.9M | $-51.2M | ||
| Q2 25 | $9.3M | $-44.9M | ||
| Q1 25 | $8.1M | $-33.9M | ||
| Q4 24 | $7.5M | $49.9M | ||
| Q3 24 | $6.3M | $-19.1M | ||
| Q2 24 | $6.7M | $-12.5M | ||
| Q1 24 | $5.9M | $-10.3M |
| Q4 25 | 52.0% | -147.6% | ||
| Q3 25 | 47.4% | -163.7% | ||
| Q2 25 | 53.5% | -302.9% | ||
| Q1 25 | 44.6% | -466.3% | ||
| Q4 24 | 45.0% | 54.5% | ||
| Q3 24 | 39.6% | -1051.6% | ||
| Q2 24 | 41.2% | -3068.0% | ||
| Q1 24 | 39.4% | — |
| Q4 25 | 46.3% | -147.1% | ||
| Q3 25 | 41.2% | -157.4% | ||
| Q2 25 | 45.6% | -285.6% | ||
| Q1 25 | 40.1% | -425.7% | ||
| Q4 24 | 41.7% | 57.7% | ||
| Q3 24 | 37.1% | -925.0% | ||
| Q2 24 | 40.6% | -2503.2% | ||
| Q1 24 | 37.3% | — |
| Q4 25 | $0.60 | $-0.41 | ||
| Q3 25 | $0.52 | $-0.52 | ||
| Q2 25 | $0.55 | $-0.46 | ||
| Q1 25 | $0.47 | $-0.35 | ||
| Q4 24 | $0.44 | $0.52 | ||
| Q3 24 | $0.37 | $-0.20 | ||
| Q2 24 | $0.39 | $-0.13 | ||
| Q1 24 | $0.34 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $258.3M | $114.3M |
| Total Assets | $3.1B | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $245.0M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | — | $240.1M | ||
| Q1 25 | $155.5M | $275.7M | ||
| Q4 24 | $166.4M | $314.0M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | $190.4M | $218.7M | ||
| Q1 24 | — | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $258.3M | $114.3M | ||
| Q3 25 | $248.2M | $147.7M | ||
| Q2 25 | $238.8M | $192.3M | ||
| Q1 25 | $229.0M | $229.0M | ||
| Q4 24 | $218.4M | $256.8M | ||
| Q3 24 | $216.3M | $201.0M | ||
| Q2 24 | $206.0M | $215.2M | ||
| Q1 24 | $199.2M | $223.9M |
| Q4 25 | $3.1B | $327.7M | ||
| Q3 25 | $3.1B | $372.8M | ||
| Q2 25 | $3.0B | $313.5M | ||
| Q1 25 | $3.0B | $327.3M | ||
| Q4 24 | $3.0B | $351.2M | ||
| Q3 24 | $2.9B | $217.6M | ||
| Q2 24 | $2.8B | $222.0M | ||
| Q1 24 | $2.9B | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-43.5M |
| Free Cash FlowOCF − Capex | $6.2M | — |
| FCF MarginFCF / Revenue | 28.0% | — |
| Capex IntensityCapex / Revenue | 0.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $-43.5M | ||
| Q3 25 | $7.0M | $-47.0M | ||
| Q2 25 | $28.0M | $-39.6M | ||
| Q1 25 | $7.3M | $-40.7M | ||
| Q4 24 | $5.3M | $42.0M | ||
| Q3 24 | $2.1M | $-14.5M | ||
| Q2 24 | $24.9M | $-7.3M | ||
| Q1 24 | $5.6M | $-6.7M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.5M | $-47.2M | ||
| Q2 25 | $27.3M | $-39.6M | ||
| Q1 25 | $7.3M | $-40.8M | ||
| Q4 24 | $5.1M | $41.7M | ||
| Q3 24 | $2.0M | $-14.6M | ||
| Q2 24 | $23.4M | $-7.3M | ||
| Q1 24 | $4.9M | $-6.8M |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 30.4% | -145.4% | ||
| Q2 25 | 133.3% | -252.2% | ||
| Q1 25 | 36.1% | -512.1% | ||
| Q4 24 | 28.6% | 48.2% | ||
| Q3 24 | 11.8% | -706.3% | ||
| Q2 24 | 141.2% | -1463.4% | ||
| Q1 24 | 31.3% | — |
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 1.9% | 0.6% | ||
| Q2 25 | 3.4% | 0.3% | ||
| Q1 25 | 0.3% | 1.1% | ||
| Q4 24 | 1.0% | 0.3% | ||
| Q3 24 | 0.9% | 6.8% | ||
| Q2 24 | 9.1% | 7.6% | ||
| Q1 24 | 4.2% | — |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | 0.84× | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
